[1]李盛华,马新换,徐志伟.防疫常态下“甘肃方剂”产业化研究的对策与建议[J].西部中医药,2023,36(02):44-47.[doi:10.12174/j.issn.2096-9600.2023.02.10]
　LI Shenghua,MA Xinhuan,XU Zhiwei.Countermeasure and Suggestions on Industrialization Research of “Gansu Prescriptions” under the Normal State of Epidemic Prevention[J].Western Journal of Traditional Chinese Medicine,2023,36(02):44-47.[doi:10.12174/j.issn.2096-9600.2023.02.10]
点击复制

防疫常态下“甘肃方剂”产业化研究的对策与建议
分享到：

《西部中医药》[ISSN:2096-9600/CN:62-1204/R]

卷:
36
期数:
2023年02期
页码:
44-47
栏目:
出版日期:
2023-02-15

文章信息/Info

Title:
Countermeasure and Suggestions on Industrialization Research of “Gansu Prescriptions” under the Normal State of Epidemic Prevention
作者:
李盛华1, 马新换2, 徐志伟1
1.甘肃省中医院，甘肃 兰州 730050
2.甘肃省第二人民医院，甘肃 兰州 730099
Author(s):
LI Shenghua1, MA Xinhuan2, XU Zhiwei1
1.Gansu Provincial Hospital of Traditional Chinese Medicine, Lanzhou 730050, China
2.Second Provincial People's Hospital of Gansu, Lanzhou 730099, China
关键词:
甘肃方剂; 常态化疫情防控; 产业化; 对策与建议
Keywords:
prescriptions; normalized epidemic prevention and control; industrialization; countermeasures and suggestions
分类号:
R563.1
DOI:
10.12174/j.issn.2096-9600.2023.02.10
文献标志码:
A
摘要:
“甘肃方剂”是基于防疫常态下甘肃中医临床实践与特色，经由省内名家归纳总结的系列方药，在省内外及国内外的防疫实践过程中发挥着重要的作用。但在其研发、生产及应用等过程中，“甘肃方剂”暴露出的研发深度不足、生产配套不够、应用广度有限等问题，严重制约其产业化发展。为了进一步促进“甘肃方剂”产业化发展，以便更好地服务于甘肃省防疫工作，现就“甘肃方剂”的发展现状及存在问题进行小结，并适时提出解决方案与建议，以期为“甘肃方剂”后续产业化发展指明方向。
Abstract:
Gansu prescriptions, based on clinical practice and characteristics of TCM in Gansu under the normalized epidemic prevention and control, are a series of prescriptions summarized by famous TCM doctors in Gansu province, and these prescriptions are playing the crucial role in the practice of epidemic practice inside and outside the province, at home and abroad. In the process of research and development, production and application, the problems including insufficient research and development, inadequate production supporting facilities and limited application range, emerged in Gansu prescriptions, seriously constrain its industrialization development of the prescription. The paper sums up the development status and the existing problems of Gansu prescriptions, and timely raises the solution and suggestions in order to further promote the industrialization development of the prescription, as as to better service for the work of epidemic prevention in Gansu province, in the hope of finding out the direction of the subsequent development of the prescriptions.

相似文献/References:

[1]王兰娣,杨志华,王建云,等.“甘肃方剂”救治新型冠状病毒肺炎患者临床效果分析[J].西部中医药,2020,33(S1):54.
　WANG Landi,YANG Zhihua,WANG Jianyun,et al.Clinical Analysis of Gansu Prescriptions in Treating COVID-19[J].Western Journal of Traditional Chinese Medicine,2020,33(02):54.
[2]王兰娣,杨志华,王建云,等.“甘肃方剂”救治新型冠状病毒肺炎患者临床疗效分析[J].西部中医药,2021,34(12):9.[doi:10.12174/j.issn.2096-9600.2021.12.03]
　WANG Landi,YANG Zhihua,WANG Jianyun,et al.Clinical Analysis of "Gansu Prescriptions" in Treating COVID-19[J].Western Journal of Traditional Chinese Medicine,2021,34(02):9.[doi:10.12174/j.issn.2096-9600.2021.12.03]

备注/Memo

备注/Memo:
李盛华（1959—），男，主任医师，教授，博士研究生导师。岐黄学者，享受国务院特殊津贴专家，卫生部有突出贡献中青年专家，甘肃省优秀专家，甘肃省名中医，甘肃省领军人才第一层次，甘肃省“555”创新人才，甘肃省“333”科技人才，甘肃省卫生厅跨世纪学术技术带头人，甘肃省中医院首席主任医师，国家级重点学（专）科—骨科学科带头人，中华中医药学会理事，中华中医药学会骨伤分会副主任委员，中国中西医结合学会微创专业委员会主任委员，中国中西医结合学会脊柱医学专业委员会常务理事，甘肃省中医药学会副会长，甘肃省中西医结合学会
更新日期/Last Update: 2023-02-15